162 related articles for article (PubMed ID: 24213230)
1. My burning issues in neuroendocrine tumours (NET).
Kiesewetter B; Raderer M
Memo; 2018; 11(4):313-316. PubMed ID: 30595757
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians.
Sharma J; Duque M; Saif MW
Therap Adv Gastroenterol; 2013 Nov; 6(6):474-90. PubMed ID: 24179483
[TBL] [Abstract][Full Text] [Related]
3. [Medicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system.].
Auernhammer CJ; Spitzweg C; Heinemann V; Göke B
Internist (Berl); 2012 Feb; ():. PubMed ID: 22294240
[TBL] [Abstract][Full Text] [Related]
4. Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs).
Megdanova-Chipeva VG; Lamarca A; Backen A; McNamara MG; Barriuso J; Sergieva S; Gocheva L; Mansoor W; Manoharan P; Valle JW
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708210
[TBL] [Abstract][Full Text] [Related]
5. Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions.
Pellat A; Cottereau AS; Palmieri LJ; Soyer P; Marchese U; Brezault C; Coriat R
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070035
[TBL] [Abstract][Full Text] [Related]
6. Practical management of toxicities associated with targeted therapies for advanced gastroenteropancreatic neuroendocrine tumors.
Cuyle PJ; Prenen H
Ann Gastroenterol; 2018; 31(2):140-150. PubMed ID: 29507461
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48].
Hernando J; Roca-Herrera M; García-Álvarez A; Raymond E; Ruszniewski P; Kulke MH; Grande E; Carbonero RG; Castellano D; Salazar R; Ibrahim T; Teule A; Alonso V; Fazio N; Valle JW; Tafuto S; Carmona A; Navarro V; Capdevila J
Eur J Cancer; 2024 May; 203():114061. PubMed ID: 38609739
[No Abstract] [Full Text] [Related]
8. Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatment.
Díez M; Teulé A; Salazar R
Ann Gastroenterol; 2013; 26(1):29-36. PubMed ID: 24714698
[TBL] [Abstract][Full Text] [Related]
9. A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments.
Özdirik B; Tacke F; Benz F; Amthauer H; Fehrenbach U; Roderburg C; Jann H
Medicine (Baltimore); 2020 Jun; 99(25):e20820. PubMed ID: 32569231
[TBL] [Abstract][Full Text] [Related]
10. Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison.
Signorovitch J; Swallow E; Kantor E; Wang X; Klimovsky J; Haas T; Devine B; Metrakos P
Exp Hematol Oncol; 2013 Dec; 2(1):32. PubMed ID: 24314093
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic therapy for neuroendocrine tumours].
Petrányi A; Bodoky G
Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neuroendocrine tumors: entering a new era.
Oberstein PE; Remotti H; Saif MW; Libutti SK
JOP; 2012 Mar; 13(2):169-73. PubMed ID: 22406593
[TBL] [Abstract][Full Text] [Related]
13. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.
Pasricha G; Padhi P; Daboul N; Monga DK
Clin Ther; 2017 Nov; 39(11):2146-2157. PubMed ID: 29173655
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of gastroenteropancreatic neuroendocrine tumors.
Rinke A; Michl P; Gress T
Cancers (Basel); 2012 Feb; 4(1):113-29. PubMed ID: 24213230
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
16. Advances in the management of unresectable or metastatic pancreatic neuroendocrine tumors: chemotherapy, targeted therapy, hormonal treatment, and future directions.
Bilici A
Asian Pac J Cancer Prev; 2015; 16(6):2151-9. PubMed ID: 25824731
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
